NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









EMPIRI INC.

EMPIRI INC.

Private
Houston, TexasHealthcare & Life Scienceshttps://empiricancer.com/

Last Round

Grant

Nov 19, 2025

Total Funding Raised

$3.47M

Company Overview

EMPIRI INC. is a biotechnology company that provides personalized cancer treatment diagnostics using its proprietary E-slice 3D tumor culture platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

precision oncologyfunctional drug screening3D tumor cultureex-vivo drug testingcontract research organizationCROtumor profilingbiomarker discoveryspatial transcriptomicssingle-cell sequencingtranslational researchclinical decision supportorganoidpatient-derived modelsdrug development services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EMPIRI INC. Comps

Public and private peers based on sector, stage, and business model.

EMPIRI INC. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

EMPIRI INC. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 19, 2025
AcceleratorJun 10, 2025
GrantAug 1, 2023
GrantSep 20, 2022
AcceleratorMay 25, 2022
View all Funding Rounds

EMPIRI INC. Investors

Notable investors and investment history

EMPIRI INC. investors
InvestorRounds
National Cancer InstituteGrant
Cancer Prevention & Research Institute of TexasGrant
BioTools InnovatorAccelerator
NewchipAccelerator
National Science FoundationGrant
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2026

    Monthly visitors increased 46% MoM, reaching 1.4K.

  • Jun 10, 2025

    Led by BioTools Innovator

View all signals

EMPIRI INC. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EMPIRI INC. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EMPIRI INC.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas
Employee Range10
Year Founded2018
Last FundingNov 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.